| Ethical Issues in Drug Development | April 27, 2011 |
Richard Scheller
|
Genentech |
Entrepreneurial Thought Leaders Lecture Series |
| Views: 1032 |
|
| Video 9 of 9 from this talk |
- 59:37Developing Products that Save Lives [Entire Talk]
- 05:05Moving From Academia to Industry
- 03:18Choose Your Words Carefully
- 05:06Drug Development Process
- 03:26Pharmaceutical Market Realities
- 02:51Encouraging Innovation and Risk Taking
- 03:36Startup Opportunities in Biotechnology
- 04:41Motivating a Biotechnology Workforce
- 04:40Ethical Issues in Drug Development
Description
Genentech Executive Vice President Richard Scheller discusses some of the thought-provoking ethical issues that arise in the drug development process. To illuminate the issue, Scheller describes the painful challenges of the clinical trial placebo process, often required by the Food and Drug Administration. He also articulates some of the ethical implications related to drug costs and insurance reimbursements.
Comments 
Related Videos:
